Article
PCR-based genotyping for duplicated and deleted CYP2D6 genes.
Pharmacogenetics - 1 Aug 1996
Johansson I, Lundqvist E, Dahl M L, Ingelman-Sundberg M
Abstract excerpt
The debrisoquine hydroxylase (CYP2D6), which metabolizes more than 30 different drugs, is highly polymorphic. In subjects having either very low or very high enzyme activity, drug therapy at recommended doses using CYP2D6 substrates may lead to either increased risk of side effects or therapeutic failure. We here describe PCR-based methods for detection of alleles having either duplicated, multiduplicated or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
